Trial Analysis Characterizes SCLC Disease Progression ...Middle East

Medscape - News
Trial Analysis Characterizes SCLC Disease Progression
An exploratory analysis shows a reduction in extrathoracic metastases and prolonged time to progression or death due to any metastases with durvalumab vs placebo. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Trial Analysis Characterizes SCLC Disease Progression )

Apple Storegoogle play

Also on site :